nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing the commercial determinants of health agenda
|
Lee, Kelley |
|
|
401 |
10370 |
p. 16-17 |
artikel |
2 |
André Ilbawi: centring community-defined priorities in cancer care
|
Samarasekera, Udani |
|
|
401 |
10370 |
p. 15 |
artikel |
3 |
Application of a sex-specific GRACE score in practice
|
Kimenai, Dorien M |
|
|
401 |
10370 |
p. 22-23 |
artikel |
4 |
Application of a sex-specific GRACE score in practice – Authors' reply
|
Wenzl, Florian A |
|
|
401 |
10370 |
p. 23 |
artikel |
5 |
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
|
Merola, Joseph F |
|
|
401 |
10370 |
p. 38-48 |
artikel |
6 |
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
|
McInnes, Iain B |
|
|
401 |
10370 |
p. 25-37 |
artikel |
7 |
Bimekizumab in psoriatic arthritis: a great leap forward?
|
Queiro, Rubén |
|
|
401 |
10370 |
p. 2-3 |
artikel |
8 |
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
|
Mulliez, Thomas |
|
|
401 |
10370 |
p. 23-24 |
artikel |
9 |
Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? – Authors' reply
|
Chua, Boon H |
|
|
401 |
10370 |
p. 24 |
artikel |
10 |
Cardiovascular risk in systemic autoimmune diseases
|
Cafaro, Giacomo |
|
|
401 |
10370 |
p. 21-22 |
artikel |
11 |
Cardiovascular risk in systemic autoimmune diseases
|
Funada, Satoshi |
|
|
401 |
10370 |
p. 21 |
artikel |
12 |
Cardiovascular risk in systemic autoimmune diseases – Authors' reply
|
Conrad, Nathalie |
|
|
401 |
10370 |
p. 22 |
artikel |
13 |
Climate change, health, and discrimination: action towards racial justice
|
Deivanayagam, Thilagawathi Abi |
|
|
401 |
10370 |
p. 5-7 |
artikel |
14 |
COVID-19 and other adult vaccines can drive global disease prevention
|
Agus, David B |
|
|
401 |
10370 |
p. 8-10 |
artikel |
15 |
Eldryd Hugh Owen Parry
|
Watts, Geoff |
|
|
401 |
10370 |
p. 20 |
artikel |
16 |
Focusing on the eye signs of Alport syndrome in a 40-year-old man who previously had a kidney transplant and hearing loss
|
Kovalchuk, Bogdana |
|
|
401 |
10370 |
p. e1 |
artikel |
17 |
Increasing humanitarian concerns for 2023
|
Zarocostas, John |
|
|
401 |
10370 |
p. 13-14 |
artikel |
18 |
Monkeypox
|
Mitjà, Oriol |
|
|
401 |
10370 |
p. 60-74 |
artikel |
19 |
Offline: Health's intercultural turn
|
Horton, Richard |
|
|
401 |
10370 |
p. 12 |
artikel |
20 |
Rezafungin and invasive candida infections: a new game changing antifungal?
|
Guinea, Jesús |
|
|
401 |
10370 |
p. 3-5 |
artikel |
21 |
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
|
Thompson III, George R |
|
|
401 |
10370 |
p. 49-59 |
artikel |
22 |
The Lancet at 200: a start, but more to do
|
The Lancet, |
|
|
401 |
10370 |
p. 1 |
artikel |
23 |
The Lancet Commission on 21st-Century Global Health Threats
|
Kanem, Natalia |
|
|
401 |
10370 |
p. 10-11 |
artikel |
24 |
The legacy of the COVID-19 pandemic for childhood vaccination in the USA
|
Opel, Douglas J |
|
|
401 |
10370 |
p. 75-78 |
artikel |
25 |
Unhealthy histories: sports and addictive sponsorship
|
Greenwood, Anna |
|
|
401 |
10370 |
p. 18-19 |
artikel |